Detail of > 56974-61-9
- MSDS Download

- CAS Number:
- 56974-61-9
- Name:
Gabexate mesylate
- Formula:
- C17H27N3O7S
- Molecular Structure:

- Synonyms:
- p-Hydroxybenzoic acid ethyl ester 6-guanidinohexanoate mesilate;Ethyl p-(6-guanidinohexanoxyloxy)benzoate methanesulfonate;Benzoic acid, 4-((6-((aminoiminomethyl)amino)-1-oxohexyl)oxy)-, ethyl ester, monomethanesulfonate;FOY 007;Arodate (TN);[N-[5-(4-ethoxycarbonylphenoxy)carbonylpentyl]carbamimidoyl]azanium; methanesulfonate;Benzoic acid,4-[[6-[(aminoiminomethyl)amino]- 1-oxohexyl]oxy]-,ethyl ester,monomethanesulfonate;Ethyl p-hydroxybenzoate 6-guanidinohexanoate;39492-01-8;Gabexate mesilate (JP14);Gabexate mesilate;FOY;FOY-S 983;Gabexate monomethanesulfonate;Gabexatum [INN-Latin];Gabexato [INN-Spanish];Gabexato mesilato [Spanish];Ethyl p-(6-guanidinohexanoyloxy) benzoate methanesulfonate;gabexate mesylate;4-((6-((aminoiminomethyl)amino)-1-oxohexyl)oxyl)benzoic acid ethyl ester mesylate salt;
- Molecular Weight:
- 417.53
- Boiling Point:
- 508.6 °C at 760 mmHg
- Flash Point:
- 261.4 °C
- Appearance:
- white crystal
- Hazard Symbols:
Xn
Related products
Other Products
- Titanium Dioxide Carbon black Glutathione Adenosine Cable pulling lubricant
- 56238-63-2Cefuroxime sodium
- 56974-61-9Gabexate mesylate
- 732-26-3Phenol,2,4,6-tris(1,1-dimethylethyl)-
- 152735-23-44H-1-Benzopyran-8-carboxamide,N-[3-[4-(2-methoxyphenyl)-1-piperazinyl]propyl]-3-methyl-4-oxo-2-phenyl-
- 6333-43-32,3-Dimethoxyquinoxaline
- 18691-97-9Urea,N-2-benzothiazolyl-N,N'-dimethyl-
- 3381-88-22alpha,17alpha-Dimethyldihydrotestosterone
- 73-31-4Melatonine
- 13388-75-5Benzeneacetonitrile,3,5-dimethoxy-
- 106287-90-51H-Indole-3-aceticacid, 5-methoxy-2-methyl-1-(2-oxo-2-phenylethyl)-
- 118134-30-81,4-Dioxaspiro[4.5]decane-2-methanamine,8-(1,1-dimethylethyl)-N-ethyl-N-propyl-
- 869-52-3TTHA
- 544-19-4Formic acid, copper(2+)salt (2:1)
- 115909-22-3beta-D-Glucopyranoside,2-(3-hydroxy-4-methoxyphenyl)ethyl O-a-L-arabinopyranosyl-(1®6)-O-[6-deoxy-a-L-mannopyranosyl-(1®3)]-,4-[(2E)-3-(4-hydroxy-3-methoxyphenyl)-2-propenoate]
- 87-67-2Choline bitartrate
Refine Suppliers Do you want your product ranking ahead? Know what is 'Top Seller'!
- Supplier Location:
China (Mainland)(18)
- Business Type:
- Importer/Exporter(12)Lab/Research institutions(1)Other(1)
- Certificates:
- ISO(1) Production License (0)
Please post your buying leads,so that our qualified suppliers
will soon contact you!
*Required Fields
Reference
- Pancreatic secretion in the rat influenced by the low molecular weight serine proteinase inhibitor Gabexate mesilate
- Pancreatic secretion in the rat influenced by the low molecular weight serine proteinase inhibitor Gabexate mesilate. Keim, V.; Goeke, B. (Inst. Appl. Physiol., Univ. Marburg, Fed. Rep. Ger.). Eur. J. Clin. Invest., 16(6), 519-25 (English) 1986. CODEN: EJCIB8. ISSN: 0014-2972. DOCUMENT TYPE: Journal CA Section: 1 (Pharmacology) The effect of i.v. or intragastric administration of the synthetic proteinase inhibitor Gabexate mesilate (GM) [56974-61-9] on the pancreas of rats was investigated. Infused i.v. at 4 mg kg-1 h-1, GM inhibited both basal or caerulein (0.2 mg kg-1 h-1)-simulated pancreatic protein secretion. Intracellular transport and secretion of newly synthesized pancreatic enzymes was not influenced by i.v. infusion of GM. Intragastric administration of GM (400 mg kg-1) on 4 consecutive days increased pancreatic wet wt., protein and enzyme content of the gland. A preferential increase of proteinases above glucosidases was obsd. Pancreatic lobules from inhibitor-treated rats released 30% less amylase in response to caerulein or carbachol when the rate of discharge was expressed in percent of initial content. The secretion rate expressed in ku amylase/mg DNA was 2-fold higher than in controls. In pancreatic duct cannulated rats GM (400 mg kg-1 h-1), introduced intragastrically on 5 consecutive days, stimulated vol.-bicarbonate and protein secretion rate, the secretory response on the 5th day being higher than on the 1st day. Enzyme pattern in pancreatic juice changed characteristically: mainly the amt. of acidic proteinases increases, whereas the amt. of the basic isoforms was altered only slightly.
- Influence of the anti-inflammatory serine esterase inhibitor gabexate mesilate (Foy) on aggregation, locomotion and adhesion of polymorphonuclear leukocytes
- Influence of the anti-inflammatory serine esterase inhibitor gabexate mesilate (Foy) on aggregation, locomotion and adhesion of polymorphonuclear leukocytes. Damerau, B.; Wuestefeld, H.; Fricke, D.; Kunze, H. (Dep. Biochem. Pharmacol., Max-Planck-Inst. Exp. Med., Goettingen D-3400, Fed. Rep. Ger.). Agents Actions, 15(5-6), 594-9 (English) 1984. CODEN: AGACBH. ISSN: 0065-4299. DOCUMENT TYPE: Journal CA Section: 1 (Pharmacology) The effects of the anti-inflammatory serine esterase inhibitor, gabexate mesilate (Foy) [56974-61-9] were studied, on locomotion, autoaggregation and adhesion of polymorphonuclear leukocytes stimulated with the complement peptide C5a-desArg1. The drug inhibited aggregation as well as spontaneous and directed migration of human leukocytes at concns. of about 10-3 M. Adhesion of peritoneal guinea pig leukocytes to autologous aortic strips was reduced at about 20 times lower drug concns. The inhibitory drug effects were highly time- and temp.-dependent. Expts. with the 3 major drug metabolites, pHB and eGC, indicate that gabexate mesilate is not active by itself but rather by its hydrolytic arom. metabolite, pHB. The results further suggest that the inhibitory effects on leukocyte activities obsd. are not related to the anti-inflammatory effects of gabexate mesilate.
- About us
- |
- Payment
- |
- Contact us
- |
- Links
- |
- Help Center
- |
- Disclaimer
- |
- Add to favorite
- | SiteMap
- |
- Product SiteMap
- |
- Manufacturers
- |
- Suppliers
©2008 LookChem.com,License:ICP NO.:Zhejiang10014259
[Hangzhou]86-571-85317600,85317603,85317620

